Showing results (151-160 of 297) with videos related to

Sort By:
Pageof 30
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2002
Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancerSridhar Mani, Charles M Rudin, Katie Kunkel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 4, 2014
UGT1A and UGT2B genetic variation alters nicotine and nitrosamine glucuronidation in european and african american smokersCatherine A Wassenaar, David V Conti, Soma Das, et al.
Clinical Pharmacology and Therapeutics|April 3, 2020
Pharmacogenomic-Based Decision Support to Predict Adherence to MedicationsCarlton Christian, Brittany A Borden, Keith Danahey, et al.
Cancer Chemotherapy and Pharmacology|September 7, 2004
A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseasesOlatoyosi M Odenike, Ronald M Sobecks, Linda Janisch, et al.
Clinical Pharmacology and Therapeutics|December 24, 2002
Population pharmacokinetic model for irinotecan and two of its metabolites, SN-38 and SN-38 glucuronideCheri Enders Klein, Elora Gupta, Joel M Reid, et al.
Plos One|May 15, 2013
A novel fully automated molecular diagnostic system (AMDS) for colorectal cancer mutation detectionShiro Kitano, Jamie Myers, Junko Nakamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 26, 2019
Ethical Framework for Including Research Biopsies in Oncology Clinical Trials: American Society of Clinical Oncology Research StatementLaura A Levit, Jeffrey M Peppercorn, Alda L Tam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2008
Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinomaOlwen M Hahn, Cheng Yang, Milica Medved, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2015
Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering CommitteeLesley Seymour, Susan Groshen, Gary L Rosner, et al.
Pageof 30